default author photo

Sandra Tessa Hattenhauer

Heinrich Heine University Dusseldorf

SCHOLARLY PAPERS

2

DOWNLOADS

170

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Early Combination Therapy of COVID-19 in High-Risk Patients

Number of pages: 22 Posted: 02 Aug 2023
Heinrich Heine University Dusseldorf - Clinic of Gastroenterology, Hepatology and Infectious Diseases, Heinrich Heine University Dusseldorf - Clinic of Gastroenterology, Hepatology and Infectious Diseases, Heinrich Heine University Dusseldorf, Heinrich Heine University Dusseldorf, Heinrich Heine University Dusseldorf, Heinrich Heine University Dusseldorf, Heinrich Heine University Dusseldorf, University of Cologne - Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD), Heinrich Heine University Dusseldorf, Heinrich Heine University Dusseldorf, Heinrich Heine University Dusseldorf, Independent, Heinrich Heine University Dusseldorf, Heinrich Heine University Dusseldorf - Clinic of Gastroenterology, Hepatology and Infectious Diseases, Heinrich Heine University Dusseldorf, Heinrich Heine University Dusseldorf - Clinic of Gastroenterology, Hepatology and Infectious Diseases, Heinrich Heine University Dusseldorf, University Bonn, Heinrich Heine University Dusseldorf, University of Bonn - Department of Internal Medicine I, Heinrich Heine University Dusseldorf, Heinrich Heine University Dusseldorf, Heinrich Heine University Dusseldorf, Heinrich Heine University Dusseldorf - Clinic of Gastroenterology, Hepatology and Infectious Diseases, Heinrich Heine University Dusseldorf - Clinic of Gastroenterology, Hepatology and Infectious Diseases, University of Bonn - Department of Internal Medicine I, University of Bonn, University of Cologne - Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD) and Heinrich Heine University Dusseldorf
Downloads 147 (508,926)

Abstract:

Loading...

COVID-19, immunocompromised host, dual anti-SARS-CoV-2 therapies, combination therapy, prolonged viral shedding, individualized therapeutic approaches

2.

CD103+ tissue-resident T-cells in head and neck squamous cell carcinomas of patients treated with anti-PD-1 therapy

Number of pages: 22 Posted: 29 Oct 2025
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Heinrich Heine University Dusseldorf, Heinrich Heine University Dusseldorf, affiliation not provided to SSRN, University of Bonn - University Hospital Bonn (UKB), Heinrich Heine University Dusseldorf and affiliation not provided to SSRN
Downloads 23 (1,424,331)

Abstract:

Loading...

immune check point inhibition (ICI), head and neck sqamous cell carcinoma (HNSCC), CD103+ tissue-resident T cells